Global Eubiotics Market: Focus on Offering Type (Probiotics, Prebiotics, Organic acids), Applications (Gut Health, Immunity), Livestock Type (Swine, Poultry, Aquaculture) and End User - Analysis and Forecast, 2020-2025

"Global Eubiotics Market Anticipated to Reach $7.74 Billion by 2025."

Market Report Coverage - Global Eubiotics Market

Market Segmentation

• Offering Type- Probiotics (Lactobacilli, Bifidobacterial, Streptococcus Thermophilus, Others), Prebiotics(Fructo-Oligosaccharides, Galacto-Oligosaccharides, and Mannan-Oligosaccharide), Organic Acids (Formic Acid, Lactic Acid, Fumaric Acid, Propionic Acid, and Acetic Acid) and Essential Oils

• Application - Gut Health, Immunity, Yield and Others

• Livestock Type - Swine, Poultry, Ruminants, Aquaculture, and Others

• Form - Liquid and Solid form/Dry Form

• End User - Humans and Animals (Industrial Livestock and Domesticated animals)

• Packaging Type - Stand-up Pouches/ Portion Control and Bulk Packaging (Packet Packaging and Bucket Packaging)

Regional Segmentation

• North America - U.S., Canada, Mexico, and Rest-of-North America

• South America- Brazil, Argentina, and Rest-of-South America

• Europe - Germany, France, Italy, Spain, and Rest-of-Europe

• U.K

• China

• Asia-Pacific&Japan - Japan, Australia, India, South Korea and Rest-of-Asia-Pacific Japan

• Middle East & Africa - U.A.E, South Africa, Saudi Arabia and Rest-of-Middle East & Africa

Growth Drivers

• Increase in consumption and production of meat and meat-based products

• Supplanting antibiotic growth promoters (AGPs) with eubiotics

• Rapid increases in the livestock disease

Market Challenges

• Complexity in trading due to stringent government policies

• Lack of sufficient scientific evidence

• Impact of COVID-19 on supply chain

Market Opportunities

• Rapid investment in animal nutrition

• Opportunity to invest on consumer awareness amid COVID-19

Key Eubiotics Companies Profiled

• Public Players: Anpario plc, Archer Daniels Midland, BASF SE, BioGaia AB, Bluestar Adisseo Co, Chr. Hansen Holding A/S, DuPont de Nemours, Inc., Koninklijke DSM N.V., Novozymes A/S, and Yara International ASA

• Private Players: ADDCON GmbH, BEHN MEYER, BENEO GmbH, Calpis Co., Ltd., Cargill, Inc., Kemin Industries, Inc., LLEMAND Inc., Lesaffre, MSPrebiotics Inc., Neospark Drugs and Chemicals Private Limited, Novus International, Inc, and Roquette Freres

Key Questions Answered in this Report:

• What is the estimated global eubiotics market size in terms of value during the period 2019-2025?

• What is the expected future scenario and revenue to be generated by different types of eubiotics offerings, including probiotics, prebiotics, organic acid, and essential oils?

• What is the expected future scenario and revenue to be generated by the application segments for eubiotics, including gut health, immunity, and yield, among others?

• What is the expected future scenario and revenue to be generated by eubiotics in different types of forms, including solid or dry and liquid?

• What is the expected future scenario and revenue to be generated by eubiotics in different livestock types, including poultry, pig, ruminants, and aquaculture, among others?

• What is the expected future scenario and revenue to be generated by eubiotics in different end-user types, including humans and animals?

• What is the expected future scenario and revenue to be generated by eubiotics in different packaging types, including stand-up pouches/portion control and bulk packaging?

• What is the competitive strength of the key players in the eubiotics market on the basis of the analysis of their recent developments, product offerings, and regional presence?

• What are the emerging trends in the global eubiotics market?

• What is the funding and investment landscape in the global eubiotics market?

• What are the dynamics of the global eubiotics market including market drivers, restraints, and opportunities?

• What is the SWOT analysis for leading companies in the eubiotics market?

Market Overview

The market report includes several drivers that are influencing the changing demand for and dynamics of the eubiotics industry. The eubiotics market has undergone significant and dynamic changes in the past five years, specifically with the introduction of new and advanced solutions to improve animal health and well-being. With the increase in the world population leading to a rise in the global demand for meat food and the global prohibition on the usage of antibiotics growth promoters, livestock growers are increasingly adopting eubiotics products and ingredients to increase the yield and productivity of animals. The utilization of eubiotics as an animal feed has resulted in promoting the growth and maintaining animal health by managing the gut health and reduction in the proliferation of the undesirable pathogenic bacteria. As a result, the eubiotics market is anticipated to progress due to the ever-growing affinity for more convenient animal feed solutions than the traditional methods.

Eubiotics market encompasses a wide array of offerings,including probiotics, prebiotics, organic acids, and essential oils. The probiotics offering type comprises a board range of bacterial strain including Lactobacilli, Bifidobacteria, Streptococcus Thermophilus, and others. Prebiotics offering type consists of Fructo-Oligosaccharides, Galacto-Oligosaccharides, and Mannan-Oligosaccharide that are offered by different companies present in the market. The organic acids section of the offering type consists of formic acid, lactic acid, fumaric acid propionic acid, and acetic acid. These offerings have applications in the management of gut health, immunity, and yield, among others.

The presence of these probiotics, prebiotics, organic acids, and essential oils in the market has led to an exponential growth of the eubiotics market.

The eubiotics market is projected to grow from $5.24 billion in 2019 to $7.74 billion by 2025, growing at a CAGR of 7.06% from 2020 to 2025. High growth in the market is expected to be driven by the increasing consumption and demand for meat, growing livestock diseases, and ban on the utilization of antibiotics growth promoters. Governments of developed as wellas developing countries have also taken several initiatives to promote eubiotics, especially after the ban on antibodies growth promoters. Moreover, the increasing demand for and consumption of the meat and meat-based products is also expected to drive the market in the future.

Competitive Landscape

The exponential utilization of advanced solutions in the eubiotics market has created opportunities for companies to adopt strategies such as collaborations, joint ventures, product launches, and developments and partnerships.

The established companies in the eubiotics market are focusing more on business expansions and on finding ways to improve the existing techniques. Moreover, product launch activities have increased in the market during the last three years. Presently, the big four eubiotics companies, namely Chr. Hansen Holding A/S, Koninklijke DSM N.V., Kemin Industries, Inc., and BASF, are constantly increasing their investment in animal health improvement, by acquiring or collaborating with other companies.

Several other companies, such as Anpario plc., Novus International Inc., Lallemand, Inc, and LESAFFRE, have launched different products to compete with the market-dominant players. The wide-spread adoption of advanced feed solutions is essential for linking the gap to improve animal health effectively.

Table of Contents

1 Market Dynamics

• 1.1 Overview
• 1.2 Impact Analysis
• 1.3 Market Drivers
  • 1.3.1 Increase in Consumption and Production of Meat and Meat-Based Products
  • 1.3.2 Supplanting Antibiotic Growth Promoters (AGPs) With Eubiotics
  • 1.3.3 Rapid Increases in the Livestock Disease
• 1.4 Market Restraints
  • 1.4.1 Complexity in Trading due to Stringent Government Policies
  • 1.4.2 Lack of Sufficient Scientific Evidence
• 1.5 Market Opportunities
  • 1.5.1 Rapid Investment to Enhance Animal Nutrition
  • 1.5.2 Opportunity to Invest on Consumer Awareness Amid COVID-19

2 Competitive Landscape

• 2.1 Key Strategies and Developments
  • 2.1.1 Business Expansions and Contracts
  • 2.1.2 New Product Launches and Development
  • 2.1.3 Mergers and Acquisitions
  • 2.1.4 Partnerships, Collaborations, and Joint Ventures
  • 2.1.5 Others (Awards and Recognitions)
• 2.2 Competitive Benchmarking of Key Eubiotics Companies

3 Industry Analysis

• 3.1 Supply Chain Analysis
• 3.2 Market Trends in the Eubiotics Market
  • 3.2.1 Shift Towards Natural Functional Ingredients
  • 3.2.2 Brand Differentiation Through Innovative Packaging
  • 3.2.3 Outbreak of Corona Pandemic Arising Immunity Concerns in Consumers
  • 3.2.4 Shift of Animal Husbandry Towards Efficient and Targeted Investments
• 3.3 Impact of COVID-19 on Eubiotics Market
  • 3.3.1 Consumer Perception
  • 3.3.2 Government Regulation and Impact on Supply Chain
  • 3.3.3 The Way Forward for the Nutrition and Supplement Industry
• 3.4 Patent Analysis
  • 3.4.1 Patent Analysis (by Status)
  • 3.4.2 Patent Analysis (by Applicant Profile)
  • 3.4.3 Patent Analysis (by Product Type)
  • 3.4.4 Patent Analysis (by Application)
• 3.5 Investment and Funding Landscape

4 Global Eubiotics Market (by Offering Type)

• 4.1 Market Overview
• 4.2 Probiotics
  • 4.2.1 Lactobacilli
  • 4.2.2 Bifidobacterium
  • 4.2.3 Streptococcus Thermophilus
  • 4.2.4 Other Probiotics
• 4.3 Prebiotics
  • 4.3.1 Inulin
  • 4.3.2 Fructo-Oligosaccharides
  • 4.3.3 Galacto-Oligosaccharides
  • 4.3.4 Mannan-Oligosaccharides
• 4.4 Organic Acids
  • 4.4.1 Formic Acid
  • 4.4.2 Lactic Acid
  • 4.4.3 Fumaric Acid
  • 4.4.4 Propionic Acid
  • 4.4.5 Others
• 4.5 Essential oils

5 Global Eubiotics Market (by Application)

• 5.1 Market Overview
• 5.2 Gut Health
• 5.3 Immunity
• 5.4 Yield Management
• 5.5 Others

6 Global Eubiotics Market (by Livestock)

• 6.1 Market Overview
• 6.2 Swine
• 6.3 Poultry
• 6.4 Ruminants
• 6.5 Aquaculture
• 6.6 Other Livestock

7 Global Eubiotics Market (by Form)

• 7.1 Market Overview
• 7.2 Solid or Dry Form
• 7.3 Liquid Form

8 Global Eubiotics Market (by End User)

• 8.1 Market Overview
• 8.2 Humans
• 8.3 Animals
  • 8.3.1 Industrial Livestock
  • 8.3.2 Domesticated Animals

9 Global Eubiotics Market (by Packaging Type)

• 9.1 Market Overview
• 9.2 Stand-up Pouches/Portion Control
• 9.3 Bulk Packaging
  • 9.3.1 Packet Packaging
  • 9.3.2 Bucket Packaging

10 Global Eubiotics Market (by Region)

• 10.1 Market Overview
• 10.2 North America
  • 10.2.1 North America (by Offering Type)
  • 10.2.2 North America Eubiotics Market (by Form)
  • 10.2.3 North America Eubiotics Market (by End User)
  • 10.2.4 North America Eubiotics Market (by Country)
    • 10.2.4.1 U.S
    • 10.2.4.2 Canada
    • 10.2.4.3 Mexico
    • 10.2.4.4 Rest-of-North America
• 10.3 South America
  • 10.3.1 South America (by Offering Type)
  • 10.3.2 South America (by Form)
  • 10.3.3 South America (by End User)
  • 10.3.4 South America Eubiotics Market (by Country)
    • 10.3.4.1 Brazil
    • 10.3.4.2 Argentina
    • 10.3.4.3 Rest-of-South America
• 10.4 U.K.
  • 10.4.1 U.K. Eubiotics Market (by Offering Type)
  • 10.4.2 U.K. Eubiotics Market (by Form)
  • 10.4.3 U.K. Eubiotics Market (by End User)
• 10.5 China
  • 10.5.1 China Eubiotics Market (by Offering Type)
  • 10.5.2 China Eubiotics Market (by Form)
  • 10.5.3 China Eubiotics Market (by End User)
• 10.6 Europe
  • 10.6.1 Europe Eubiotics Market (by Offering Type)
  • 10.6.2 Europe Eubiotics Market (by Form)
  • 10.6.3 Europe Eubiotics Market (by End User)
  • 10.6.4 Europe Eubiotics Market (by Country)
    • 10.6.4.1 Germany
    • 10.6.4.2 France
    • 10.6.4.3 Spain
    • 10.6.4.4 Italy
    • 10.6.4.5 Rest-of-Europe
• 10.7 Asia-Pacific & Japan
  • 10.7.1 Asia-Pacific & Japan Eubiotics Market (by Offering Type)
  • 10.7.2 Asia-Pacific & Japan Eubiotics Market (by Form)
  • 10.7.3 Asia-Pacific & Japan Eubiotics Market (by End User)
  • 10.7.4 Asia-Pacific & Japan Eubiotics Market (by Country)
    • 10.7.4.1 Japan
    • 10.7.4.2 India
    • 10.7.4.3 Australia
    • 10.7.4.4 South Korea
    • 10.7.4.5 Rest-of-Asia-Pacific Japan
• 10.8 Middle East and Africa
  • 10.8.1 Middle East and Africa Eubiotics Market (by Offering Type)
  • 10.8.2 Middle East and Africa Eubiotics Market (by Form)
  • 10.8.3 Middle East and Africa (by End User)
  • 10.8.4 Middle East and Africa (by Country)
    • 10.8.4.1 U.A.E
    • 10.8.4.2 Saudi Arabia
    • 10.8.4.3 South Africa
    • 10.8.4.4 Rest-of-Middle East and Africa

11 Company Profiles

• 11.1 Overview
• 11.2 Anpario plc.
  • 11.2.1 Company Overview
  • 11.2.2 Role of Anpario plc. in Global Eubiotics Market
  • 11.2.3 Financials
  • 11.2.4 SWOT ANALYSIS
• 11.3 Archer Daniels Midland
  • 11.3.1 Company Overview
  • 11.3.2 Role of Archer Daniels Midland in Global Eubiotics Market
  • 11.3.3 Financials
  • 11.3.4 SWOT ANALYSIS
• 11.4 BASF SE
  • 11.4.1 Company Overview
  • 11.4.2 Role of BASF SE in the Global Eubiotics Market
  • 11.4.3 Financials
  • 11.4.4 SWOT Analysis
• 11.5 BioGaia AB
  • 11.5.1 Company Overview
  • 11.5.2 Role of BioGaia AB in Global Eubiotics Market
  • 11.5.3 Financials
  • 11.5.4 SWOT ANALYSIS
• 11.6 Bluestar Adisseo Co
  • 11.6.1 Company Overview
  • 11.6.2 Role of Bluestar Adisseo Co in Global Eubiotics Market
  • 11.6.3 Financials
  • 11.6.4 SWOT ANALYSIS
• 11.7 Chr. Hansen Holding A/S
  • 11.7.1 Company Overview
  • 11.7.2 Role of Chr. Hansen Holding A/S in Global Eubiotics Market
  • 11.7.3 Financials
  • 11.7.4 SWOT ANALYSIS
• 11.8 DuPont de Nemours, Inc.
  • 11.8.1 Company Overview
  • 11.8.2 Role of DuPont de Nemours, Inc. in the Global Eubiotics Market
  • 11.8.3 Financials
  • 11.8.4 SWOT ANALYSIS
• 11.9 Koninklijke DSM N.V.
  • 11.9.1 Company Overview
  • 11.9.2 Role of Koninklijke DSM N.V. in Global Eubiotics Market
  • 11.9.3 Financials
  • 11.9.4 SWOT Analysis
• 11.10 Novozymes A/S
  • 11.10.1 Company Overview
  • 11.10.2 Role of Novozymes A/S in the Global Eubiotics Market
  • 11.10.3 Financials
  • 11.10.4 SWOT ANALYSIS
• 11.11 Yara International ASA
  • 11.11.1 Company Overview
  • 11.11.2 Role of Yara International ASA in Global Eubiotics Market
  • 11.11.3 Financials
  • 11.11.4 SWOT ANALYSIS
• 11.12 ADDCON GmbH
  • 11.12.1 Company Overview
  • 11.12.2 Role of ADDCON GmbH in Global Eubiotics Market
  • 11.12.3 SWOT ANALYSIS
• 11.13 BEHN MEYER
  • 11.13.1 Company Overview
  • 11.13.2 Role of BEHN MEYER in the Global Eubiotics Market
  • 11.13.3 SWOT ANALYSIS
• 11.14 BENEO GmbH
  • 11.14.1 Company Overview
  • 11.14.2 Role of BENEO GmbH in Global Eubiotics Market
  • 11.14.3 SWOT ANALYSIS
• 11.15 Calpis Co., Ltd.
  • 11.15.1 Company Overview
  • 11.15.2 Role of Calpis Co., Ltd. in Global Eubiotics Market
  • 11.15.3 SWOT ANALYSIS
• 11.16 Cargill, Inc.
  • 11.16.1 Company Overview
  • 11.16.2 Role of Cargill, Inc. in Global Eubiotics Market
  • 11.16.3 SWOT Analysis
• 11.17 Kemin Industries, Inc.
  • 11.17.1 Company Overview
  • 11.17.2 Role of Kemin Industries, Inc. in Global Eubiotics Market
  • 11.17.3 SWOT ANALYSIS
• 11.18 LALLEMAND Inc.
  • 11.18.1 Company Overview
  • 11.18.2 Role of LALLEMAND Inc. in Global Eubiotics Market
  • 11.18.3 SWOT ANALYSIS
• 11.19 Lesaffre
  • 11.19.1 Company Overview
  • 11.19.2 Role of Lesaffre in the Global Eubiotics Market
  • 11.19.3 SWOT ANALYSIS
• 11.2 MSPrebiotics Inc.
  • 11.20.1 Company Overview
  • 11.20.2 Role of MSPrebiotics Inc in Global Eubiotics Market
  • 11.20.3 SWOT ANALYSIS
• 11.21 Neospark Drugs and Chemicals Private Limited
  • 11.21.1 Company Overview
  • 11.21.2 Role of Neospark Drugs and Chemical Private Limited in the Global Eubiotics Market
  • 11.21.3 SWOT ANALYSIS
• 11.22 Novus International, Inc.
  • 11.22.1 Company Overview
  • 11.22.2 Role of Novus International, Inc. in Global Eubiotics Market
  • 11.22.3 SWOT ANALYSIS
• 11.23 Roquette Freres
  • 11.23.1 Company Overview
  • 11.23.2 Role of Roquette Freres in the Global Eubiotics Market
  • 11.23.3 SWOT ANALYSIS

12 Report Scope and Methodology

• 12.1 Scope of the Report
• 12.2 Global Eubiotics Market Segmentation
• 12.3 Global Eubiotics Market Research Methodology
  • 12.3.1 Assumptions
  • 12.3.2 Limitations
  • 12.3.3 Primary Data Sources
  • 12.3.4 Secondary Data Sources
  • 12.3.5 Data Triangulation
  • 12.3.6 Market Estimation and Forecast

List of Tables

• Table 1: Impact Analysis of Market Drivers
• Table 2: Impact Analysis of Market Restraints
• Table 1.1: Major Livestock Diseases (by Type and Agro-Ecological Zone)
• Table 2.1: Competitive Benchmarking of Key Companies in Global Eubiotics Market
• Table 4.1: Global Eubiotics Market (by Offering Type), $Million, 2019-2025
• Table 4.2: Micro-Organisms Used as Probiotics in Animal Feed
• Table 5.1: Global Eubiotics Market (by Application), $Million, 2019-2025
• Table 5.2: Gut Health Products by Leading Companies
• Table 5.3: Immunity Products by Leading Companies
• Table 5.4: Yield Management Products by Leading Companies
• Table 5.5: Other Applications Products by Leading Companies
• Table 6.1: Global Eubiotics Market by Livestock, $Million, 2019-2025
• Table 6.2: Eubiotics Products for Swine by Key Companies
• Table 6.4: Eubiotics Products for Poultry by Key Companies
• Table 6.5: Eubiotics Products for Ruminants by Key Companies
• Table 6.6: Aquaculture Eubiotics Products by Key Companies
• Table 6.7: Eubiotics Products for Other Livestock by Key Companies
• Table 7.1: Global Eubiotics Market (by Form), $Million, 2019-2025
• Table 8.1: Global Eubiotics Market (by End User), $Million, 2019-2025
• Table 9.1: Global Eubiotics Market by Packaging Type, $Million, 2019-2025
• Table 10.1: Global Eubiotics Market (by Region), $Million, 2019-2025
• Table 10.2: North America Eubiotics Market (by Offering Type), $Million, 2019-2025
• Table 10.3: North America Eubiotics Market (by Form), $Million, 2019-2025
• Table 10.4: North America Eubiotics Market (by End User), $Million, 2019-2025
• Table 10.5: North America Eubiotics Market (by Country), $Million, 2019-2025
• Table 10.6: South America Eubiotics Market (by Offering Type), $Million, 2019-2025
• Table 10.7: South America Eubiotics Market (by Form), $Million, 2019-2025
• Table 10.8: South America Eubiotics Market (by End User), $Million, 2019-2025
• Table 10.9: South America Eubiotics Market (by Country), $Million, 2019-2025
• Table 10.10: U.K. Eubiotics Market (by Offering Type), $Million, 2019-2025
• Table 10.11: U.K. Eubiotics Market (by Form), $Million, 2019-2025
• Table 10.12: U.K. Eubiotics Market (by End User), $Million, 2019-2025
• Table 10.13: China Eubiotics Market (by Offering Type), $Million, 2019-2025
• Table 10.14: China Eubiotics Market (by Form), $Million, 2019-2025
• Table 10.15: China Eubiotics Market (by End User), $Million, 2019-2025
• Table 10.16: Europe Eubiotics Market (by Offering Type), $Million, 2019-2025
• Table 10.17: Europe Eubiotics Market (by Form), $Million, 2019-2025
• Table 10.18: Europe Eubiotics Market (by End User), $Million, 2019-2025
• Table 10.19: Europe Eubiotics Market (by Country), $Million, 2019-2025
• Table 10.20: Asia-Pacific & Japan Eubiotics Market (by Offering Type), $Million, 2019-2025
• Table 10.21: Asia-Pacific & Japan Eubiotics Market (by Form), $Million, 2019-2025
• Table 10.22: Asia-Pacific & Japan Eubiotics Market (by End User), $Million, 2019-2025
• Table 10.23: Asia-Pacific & Japan Eubiotics Market (by Country), $Million, 2019-2025
• Table 10.24: Middle East and Africa Eubiotics Market (by Offering Type), $Million, 2019-2025
• Table 10.25: Middle East and Africa Eubiotics Market (by Form), $Million, 2019-2025
• Table 10.26: Middle East and Africa Eubiotics Market (by End User), $Million, 2019-2025
• Table 10.27: Middle East and Africa Eubiotics Market (by Country), $Million, 2019-2025
• Table 11.1: Anpario plc.: Product Portfolio
• Table 11.2: Archer Daniels Midland Product Portfolio
• Table 11.3: BASF SE: Product Portfolio
• Table 11.4: BioGaia AB: Product Portfolio
• Table 11.5: Bluestar Adisseo Co: Product Portfolio
• Table 11.6: Chr. Hansen Holding A/S: Product Portfolio
• Table 11.7: DuPont de Nemours, Inc: Product Portfolio
• Table 11.8: Koninklijke DSM N.V. Product Portfolio
• Table 11.9: Novozymes A/S: Product Portfolio
• Table 11.10: Yara International ASA Product Portfolio
• Table 11.11: ADDCON GmbH: Product Portfolio
• Table 11.12: BEHN MEYER: Product Portfolio
• Table 11.13: BENEO GmbH Product Portfolio
• Table 11.14: Calpis Co., Ltd. Product Portfolio
• Table 11.15: Cargill, Inc.: Product Portfolio
• Table 11.16: Kemim Industries, Inc.: Product Portfolio
• Table 11.17: LALLEMAND Inc. Ltd.: Product Portfolio
• Table 11.18: Lesaffre Product Portfolio
• Table 11.19: MSPrebiotics Inc.: Product Portfolio
• Table 11.20: Neospark Drugs and Chemical Private Limited: Product Portfolio
• Table 11.21: Novus International, Inc.: Product Portfolio
• Table 11.22: Roquette Freres: Product Portfolio

List of Figures

• Figure 1: Macroeconomic Trends Impacting the Global Eubiotics Market
• Figure 2: Drivers and Restraints: Global Eubiotics Market
• Figure 3: Global Eubiotics Market Snapshot
• Figure 4: Global Eubiotics Market (by Offering Type), $Million, 2019 and 2025
• Figure 5: Global Eubiotics Market (by Application), $Million, 2019 and 2025
• Figure 6: Global Eubiotics Market (by Livestock Type), $Million, 2019 and 2025
• Figure 7: Global Eubiotics Market (by Form), $Million, 2019 and 2025
• Figure 8: Global Eubiotics Market (by End User), $Million, 2019 and 2025
• Figure 9: Global Eubiotics Market (by Packaging Type), $Million, 2019 and 2025
• Figure 10: Regional Eubiotics Market, 2019-2025
• Figure 1.1: Market Dynamics and Impact Analysis
• Figure 1.2: Per Capita Consumption of Livestock Product
• Figure 2.1: Strategies Adopted by the Key Players (January 2017-March 2020)
• Figure 2.2: Share of Key Market Strategies and Developments (January 2017-March 2020)
• Figure 2.3: Business Expansions and Contracts Share (by Company)
• Figure 2.4: Product Launches and Developments Share (by Company)
• Figure 2.5: Mergers and Acquisitions Share (by Company)
• Figure 2.6: Partnerships, Collaborations, and Joint Ventures Share (by Company)
• Figure 3.1: Supply Chain Analysis of the Global Eubiotics Market
• Figure 3.2: Advantages of Natural Functional Ingredients
• Figure 3.3: Benefits of Innovative Packaging
• Figure 3.4: Benefits of Customer Oriented Packaging
• Figure 3.5: Coronavirus in Livestock: Landscape
• Figure 3.6: Efficient and Targeted Investments by Governments of Various Countries to Promote Animal Husbandry
• Figure 3.7: Key Measure to Maintain Market Profitability
• Figure 3.8: Application-Wise Patents for Eubiotics, January 2017-April 2020
• Figure 3.9: Patent Analysis, (by Status), January 2017-April 2020
• Figure 3.10: Patent Analysis, (by Applicant Profile), January 2017-April 2020
• Figure 3.11: Patent Analysis (by Product Type), January 2017-April 2020
• Figure 3.12: Patent Analysis, (by Application), January 2017 to April 2020
• Figure 3.13: Investment and Funding in Global Eubiotics Market, January 2017-April 2020
• Figure 3.14: Investment and Funding Landscape Share (by Product Offering)
• Figure 3.15: Investment and Funding Landscape Share (by Round)
• Figure 4.1: Eubiotics Products and Ingredients (by Offering Type)
• Figure 4.3: Type of Probiotics in Eubiotics Market
• Figure 4.4: Effects of Lactobacilli as Probiotics
• Figure 4.5: Global Eubiotics Market (for Prebiotics), $Million, 2019-2025
• Figure 4.6: Types of Prebiotics Offerings
• Figure 4.7: Application of Inulin
• Figure 4.8: Application of Fructo-Oligosaccharides
• Figure 4.9: Properties of Galacto-Oligosaccharides
• Figure 4.10: Application of Organic Acids
• Figure 4.11: Global Eubiotics Market (for Organic Acids), $Million, 2019-2025
• Figure 4.12: Type of Organic Acids in Eubiotics Market
• Figure 4.13: Applications of Lactic Acid
• Figure 4.14: Global Eubiotics Market (for Essential Oils), $Million, 2019-2025
• Figure 5.1: Key Application of Eubiotics
• Figure 5.2: Global Eubiotics Market (for Gut Health), $Million, 2019-2025
• Figure 5.3: Global Eubiotics Market (for Immunity), $Million, 2019-2025
• Figure 5.4: Global Eubiotics Market (for Yield Management), $Million, 2019-2025
• Figure 5.5: Global Eubiotics Market (for Other Applications), $Million, 2019-2025
• Figure 6.1: Eubiotics Market by Livestock
• Figure 6.2: Application of Eubiotics for Swine
• Figure 6.3: Global Eubiotics Market (by Swine), $Million, 2019-2025
• Figure 6.4: Factors Limiting the Use of Alternative Traditional Feed Ingredients in Poultry Feed Formulation
• Figure 6.5: Application of Eubiotics for Poultry
• Figure 6.6: Global Eubiotics Market (for Poultry), $Million, 2019-2025
• Figure 6.7: Applications of Eubiotics for Ruminants
• Figure 6.8: Global Eubiotics Market (for Ruminants), $Million, 2019-2025
• Figure 6.9: Applications of Eubiotics for Aquaculture
• Figure 6.10: Global Eubiotics Market (for Aquaculture), $Million, 2019-2025
• Figure 6.11: Global Eubiotics Market (for Other Livestock), $Million, 2019-2025
• Figure 7.1: Eubiotics Products and Ingredients by Form
• Figure 7.2: Global Eubiotics Market (for Solid or Dry Form), $Million, 2019-2025
• Figure 7.3: Global Eubiotics Market (for Liquid Form), $Million, 2019-2025
• Figure 8.1: Global Eubiotics Market (by End User)
• Figure 8.2: Mechanistic Rationale for the Use of Eubiotics
• Figure 8.3: Global Eubiotics Market (for Humans), $Million, 2019-2025
• Figure 8.4: Global Eubiotics Market (for Animals), $Million, 2019-2025
• Figure 8.5: Livestock Production Index in Key Regions
• Figure 8.6: Advantage of Eubiotics for Domesticated Animals
• Figure 9.1: Eubiotics Market (by Packaging Type)
• Figure 9.2: Global Eubiotics Market (for Stand-up Pouches/Portion Control Packaging), $Million, 2019-2025
• Figure 9.3: Benefits of Bulk Packaging
• Figure 9.4: Global Eubiotics Market (for Bulk Packaging), $Million, 2019-2025
• Figure 9.5: Types of Bulk Packaging
• Figure 10.1: Global Eubiotics Market (by Region), Market Share and CAGR
• Figure 10.2: North America Eubiotics Market, $Million, 2019-2025
• Figure 10.3: North America Eubiotics Market (by Country), $Million, 2019-2025
• Figure 10.4: U.S Animal Feed Consumption in 2016
• Figure 10.5: The U.S. Eubiotics Market, $Million, 2019-2025
• Figure 10.6: Canada Livestock Production, 2010-2016
• Figure 10.7: Canada Eubiotics Market, $Million, 2019-2025
• Figure 10.8: Mexico Eubiotics Market, $Million, 2019-2025
• Figure 10.9: Rest-of-North America in the Eubiotics Market, $Million, 2019-2025
• Figure 10.10: South America Eubiotics Market, $Million, 2019-2025
• Figure 10.11: South America Eubiotics Market (by Country), $Million, 2019 and 2025
• Figure 10.10: Estimated Feed Consumption by Species
• Figure 10.11: Brazil Eubiotics Market, $Million, 2019-2025
• Figure 10.12: Argentina Eubiotics Market, $Million, 2019-2025
• Figure 10.13: Rest-of-South America Eubiotics Market, $Million, 2019-2025
• Figure 10.14: Livestock Production Index of the U.K.
• Figure 10.15: U.K. Eubiotics Market, $Million, 2019-2025
• Figure 10.16: Livestock Production Index of China
• Figure 10.17: China Eubiotics Market, $Million, 2019-2025
• Figure 10.18: EU Livestock Sector, Key Initiative Landscape
• Figure 10.19: Europe Eubiotics Market, $Million, 2019-2025
• Figure 10.20: Europe Eubiotics Market (by Country), $Million, 2019-2025
• Figure 10.21: Adoption Rate of Innovation by German Farmers, 2016 (%)
• Figure 10.22: Germany Eubiotics Market, $Million, 2019-2025
• Figure 10.23: France Eubiotics Market, $Million, 2019-2025
• Figure 10.24: Spain Eubiotics Market, $Million, 2019-2025
• Figure 10.25: Italy Eubiotics Market, $Million, 2019-2025
• Figure 10.26: Rest-of-Europe Eubiotics Market, $Million, 2019-2025
• Figure 10.27: Asia-Pacific & Japan Eubiotics Market, $Million, 2019-2025
• Figure 10.28: Asia-Pacific & Japan Eubiotics Market (by Country), $Million, 2019-2025
• Figure 10.29: Japan Eubiotics Market, $Million, 2019-2025
• Figure 10.30: Livestock Population In India (by Species), $Million
• Figure 10.31: India Eubiotics Market, $Million, 2019-2025
• Figure 10.32: Australia Eubiotics Market, $Million, 2019-2025
• Figure 10.33: South Korea Eubiotics Market, $Million, 2019-2025
• Figure 10.34: Rest-of-Asia-Pacific Japan Eubiotics Market, $Million, 2019-2025
• Figure 10.35: Middle East and Africa Eubiotics Market, $Million, 2019-2025
• Figure 10.36: Middle East and Africa Eubiotics Market (by Country), $Million, 2019 and 2025
• Figure 10.37: Number of Livestock by Type
• Figure 10.38: U.A.E Eubiotics Market, $Million, 2019-2025
• Figure 10.39: Saudi Arabia Eubiotics Market, $Million, 2019-2025
• Figure 10.40: South Africa Eubiotics Market, $Million, 2019-2025
• Figure 10.41: Rest-of-Middle East and Africa Eubiotics Market, $Million, 2019-2025
• Figure 11.1: Share of Key Companies
• Figure 11.2: Anpario plc.: Overall Financials, 2016-2018
• Figure 11.3: Anpario plc.: Net Revenue by Regional Segment, 2016-2018
• Figure 11.4: Anpario plc.: SWOT Analysis
• Figure 11.5: Archer Daniels Midland: Overall Financials, 2017-2019
• Figure 11.6: Archer Daniels Midland: Net Revenue by Business Segment, 2017-2019
• Figure 11.7: Archer Daniels Midland: Net Revenue by Regional Segment, 2016-2018
• Figure 11.8: Archer Daniels Midland: SWOT ANALYSIS
• Figure 11.9: BASF SE: Overall Financials, 2017-2019
• Figure 11.10: BASF SE: Net Revenue by Business Segment, 2017-2019
• Figure 11.11: BASF SE: Net Revenue by Regional Segment, 2017-2019
• Figure 11.12: BASF SE: SWOT Analysis
• Figure 11.13: BioGaia AB: Overall Financials, 2017-2019
• Figure 11.14: BioGaia: Net Revenue by Business Segment, 2016-2018
• Figure 11.15: BioGaia AB: Net Revenue by Regional Segment, 2017-2019
• Figure 11.16: BioGaia AB: SWOT Analysis
• Figure 11.17: Bluestar Adisseo Co: Overall Financials
• Figure 11.18: Bluestar Adisseo Co: Net Revenue by Regional Segment, 2017-2019
• Figure 11.19: Bluestar Adisseo Co: SWOT Analysis
• Figure 11.20: Chr. Hansen Holding A/S: Overall Financials, 2017-2019
• Figure 11.21: Chr. Hansen Holding A/S: Net Revenue by Business Segment, 2017-2019
• Figure 11.22: Chr. Hansen Holding A/S: Net Revenue by Regional Segment, 2017-2019
• Figure 11.23: Chr. Hansen Holding A/s: SWOT ANALYSIS
• Figure 11.24: DuPont de Nemours, Inc.: Overall Financials, 2017-2019
• Figure 11.25: DuPont de Nemours, Inc.: Net Revenue by Business Segment, 2017-2019
• Figure 11.26: Net Revenue by Regional Segment, 2017-2019
• Figure 11.27: DuPont de Nemours, Inc: SWOT ANALYSIS
• Figure 11.28: Koninklijke DSM N.V.: Overall Financials, 2017-2019
• Figure 11.29: Koninklijke DSM N.V. Net Sales by Business Segment, 2017-2019
• Figure 11.30: Koninklijke DSM N.V.: Net Sales by Regional Segment, 2017-2019
• Figure 11.31: Koninklijke DSM N.V SWOT Analysis
• Figure 11.32: Novozymes A/S: Overall Financials, 2016-2018
• Figure 11.33: Novozymes A/S: Net Revenue by Business Segment, 2017-2019
• Figure 11.34: Novozymes A/S: Net Revenue by Regional Segment, 2016-2018
• Figure 11.35: Novozymes A/S: SWOT Analysis
• Figure 11.36: Yara International ASA: Overall Financials, 2017-2019
• Figure 11.37: Yara International ASA: Net Revenue by Business Segment, 2018 and 2019
• Figure 11.38: Yara International: Net Revenue by Regional Segment, 2017-2019
• Figure 11.39: Yara International ASA: SWOT ANALYSIS
• Figure 11.40: ADDCON GmbH: SWOT Analysis
• Figure 11.41: BEHN MEYER: SWOT Analysis
• Figure 11.42: BENEO GmbH: SWOT Analysis
• Figure 11.43: Calpis Co., Ltd.: SWOT Analysis
• Figure 11.44: Cargill, Inc.: SWOT Analysis
• Figure 11.45: Kemim Industries, Inc.: SWOT ANALYSIS
• Figure 11.46: Lallemand Inc.: SWOT Analysis
• Figure 11.47: Lesaffre: SWOT Analysis
• Figure 11.48: MSPrebiotics Inc.: SWOT ANALYSIS
• Figure 11.49: Neospark Drugs and Chemical Private Limited: SWOT Analysis
• Figure 11.50: Novus International Inc, Swot Analysis
• Figure 11.51: Roquette Freres: SWOT Analysis
• Figure 12.1: Eubiotics Market Scope
• Figure 12.2: Global Eubiotics Market Segmentation
• Figure 12.3: Report Methodology
• Figure 12.4: Primary Interviews Breakdown, by Player, Designation, and Region
• Figure 12.5: Data Triangulation
• Figure 12.6: Top Down and Bottom-Up Approaches for Market Estimation